Ascentage Pharma Group International (AAPG) Goodwill & Intangibles (2022 - 2025)

Ascentage Pharma Group International (AAPG) has reported Goodwill & Intangibles for 4 consecutive years, with $12.8 million the latest figure, recorded in Q4 2025.

• Quarterly Goodwill & Intangibles fell 8.84% year-over-year to $12.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.8 million (down 8.84% YoY) and the FY2025 annual result came in at $12.6 million, down 10.03% from the prior year.
• Goodwill & Intangibles eased to $12.8 million in Q4 2025 per AAPG's latest filing, from $13.4 million in the prior quarter.
• Over the last five years, Goodwill & Intangibles for AAPG reached as high as $14.0 million in Q4 2024 and fell as low as $4.0 million in Q4 2022.
• A 4-year average of $10.3 million and a median of $12.8 million in 2025 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2024 — Goodwill & Intangibles jumped 94.77% — and 2025, when it retreated 8.84%.
• Year by year, Goodwill & Intangibles stood at $4.0 million in 2022, then surged by 78.82% to $7.2 million in 2023, then jumped by 94.77% to $14.0 million in 2024, then retreated by 8.84% to $12.8 million in 2025.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $12.8 million, $13.4 million, and $14.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.